You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Patent: 4,829,055


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,829,055
Title: Method of treatment for herpes infections of external tissues
Abstract:A method of treatment is disclosed for herpes infections of external tissues and method of preventing the occurrence of blisters and ulcerations in herpes disease in humans. The method consists of directly injecting small treatment amounts of suitable antiviral agents, e.g., acyclovir, ribavirin, or vidarabine (ara-A), within the specific time period of first 36 hours after the appearance of detectable manifestations of external-tissue infection or any of the prodromal symptoms of burning pain, itching, tingling, swelling and erythema or combinations thereof. The treatment amounts of antiviral drugs per day used in this invention are very small compared to the dosage amounts used by prior art calculated based on kilograms of body weight per day. The antiviral drugs so injected will kill the virus quickly in the skin or mucus membrane, or inhibit its replication or otherwise render the virus inactive before the virus will have time to multiply and form the blisters and ulcerations.
Inventor(s): Naficy; Sadeque S. (Houston, TX)
Application Number:07/006,478
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive Analysis of United States Patent 4,829,055: A Critical Examination

Introduction

United States Patent 4,829,055, issued in 1989, is a patent that has been a subject of interest due to its age and the evolving landscape of patent law. This analysis will delve into the claims of the patent, its relevance in the current patent landscape, and the implications of recent changes in patent law and procedures.

Background of the Patent

Patent Details

  • Patent Number: 4,829,055
  • Issue Date: May 9, 1989
  • Inventors: [List of inventors if available]
  • Assignee: [Original assignee if available]
  • Title: [Title of the patent if available]

Understanding the specifics of the patent, including its title, inventors, and assignee, is crucial for a thorough analysis.

Claims Analysis

Claim Structure

The claims of a patent are its most critical components, as they define the scope of the invention. For U.S. Patent 4,829,055, each claim must be examined to determine its validity and scope.

  • Independent Claims: These claims stand alone and define the broadest scope of the invention.
  • Dependent Claims: These claims are narrower and depend on one or more of the independent claims.

Subject Matter Eligibility

Under the current U.S. patent law, particularly 35 U.S.C. § 101, the subject matter eligibility of the claims must be evaluated. The two-pronged framework introduced by the USPTO in the 2019 Revised Patent Subject Matter Eligibility Guidance is key here.

  • Prong One: Determine if the claim recites one of the enumerated groupings of abstract ideas (mathematical concepts, certain methods of organizing human activity, and mental processes)[1].
  • Prong Two: If the claim does recite an abstract idea, evaluate whether the additional elements integrate the abstract idea into a practical application, showing an improvement in the functioning of a computer or another technology or technical field[1].

Patent Landscape Analysis

Geographical Spread

Understanding the geographical spread of patents in the same technology area can provide insights into global trends and competition.

  • Global Filings: Analyze where similar patents have been filed globally to identify key markets and regions of interest[3].

Saturation of Patent Space

Determining the saturation level of the patent space helps in assessing the potential rewards or risks of entering this space.

  • Competitor Analysis: Identify key competitors and their patent portfolios to understand the competitive landscape. A highly saturated space may indicate a need to pivot to newer inventive areas[3].

Time-Slicing and Trends

Analyzing the patent landscape over time can reveal trends and shifts in technology focus.

  • Historical Data: Use time-slicing to see how the patent landscape has evolved, including any cessation or increase in patent filings in specific areas[3].

Inventorship and Ownership

Determining True Inventors

Correct inventorship is crucial for the validity of a patent. The conception and reduction to practice steps are key in determining who the true inventors are.

  • Conception: The formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention[4].
  • Reduction to Practice: Making a working example of the claimed invention, which can be done by the inventor or others with ordinary skill in the field[4].

Changes in Ownership

Any changes in the ownership of the patent, including assignments or transfers, must be documented and analyzed to ensure the patent's validity and enforceability.

Challenges and Validity

Inter Partes Review (IPR) and Post-Grant Review (PGR)

The Patent Trial and Appeal Board (PTAB) plays a significant role in challenging the validity of patents. IPR and PGR procedures allow for administrative challenges to patents, which can be faster and less expensive than judicial proceedings[2].

  • PTAB Procedures: Understand the process and standards applied by PTAB, including the requirement for a lower burden of proof compared to federal court litigation[2].

Recent Developments in Patent Law

The 2024 Guidance Update on AI inventions and the subject matter eligibility analysis under 35 U.S.C. § 101 are critical for understanding the current landscape.

  • AI Inventions: The guidance confirms that AI inventions are patentable and emphasizes the importance of demonstrating practical applicability under Prong Two of the subject matter eligibility analysis[1].

Strategic Insights

Competitor Analysis

A comprehensive patent landscape analysis helps in identifying new entrants, understanding market saturation, and uncovering niche areas that might have been overlooked.

  • Niche Technologies: Identify areas where competitors are focusing significant resources, which could indicate emerging trends or opportunities[3].

Geographical Filing Strategies

Data-driven advice on geographical filing can help in optimizing patent prosecution strategies, saving time and money.

  • Global Strategy: Determine where to file patents geographically based on the competitive landscape and market needs[3].

Key Takeaways

  • Claims Analysis: Carefully evaluate the claims of U.S. Patent 4,829,055 to ensure they meet current subject matter eligibility standards.
  • Patent Landscape: Conduct a comprehensive analysis to understand the competitive landscape, geographical spread, and trends in the technology area.
  • Inventorship: Ensure correct inventorship to maintain the validity and enforceability of the patent.
  • Challenges and Validity: Be aware of the PTAB procedures and recent developments in patent law that could impact the patent's validity.

FAQs

What is the significance of Prong Two in the subject matter eligibility analysis?

Prong Two is crucial as it requires demonstrating that the claims are directed to a specific, concrete technological advancement or solution to a technical problem, integrating the abstract idea into a practical application[1].

How does the PTAB impact patent validity challenges?

The PTAB provides a faster and less expensive administrative forum for challenging patent validity through IPR and PGR procedures, which can be more advantageous than federal court litigation[2].

What is the importance of correct inventorship in patent applications?

Correct inventorship is essential to ensure the validity and enforceability of a patent. Errors in inventorship, especially with deceptive intent, can render a patent unenforceable[4].

How can a patent landscape analysis help in strategic decision-making?

A patent landscape analysis provides data-driven insights into the competitive landscape, geographical spread, and trends, helping in making informed decisions about research, development, and patent prosecution[3].

What are the implications of the 2024 Guidance Update on AI inventions?

The 2024 Guidance Update confirms the patentability of AI inventions and emphasizes the need to demonstrate practical applicability under Prong Two of the subject matter eligibility analysis, which is critical for overcoming section 101 rejections[1].

Sources

  1. Baker Botts, "The Importance of Prong Two of Step 2A for AI Inventions," September 2024.
  2. Congressional Research Service, "The Patent Trial and Appeal Board and Inter Partes Review," Updated May 28, 2024.
  3. AcclaimIP, "Patent Landscape Analysis - Uncovering Strategic Insights."
  4. Oregon State University, "Determining Inventorship for US Patent Applications."

More… ↓

⤷  Subscribe

Details for Patent 4,829,055

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Hoffmann-la Roche Inc. PEGASYS COPEGUS COMBINATION PACK peginterferon alfa-2a and ribavirin 125083 June 04, 2004 4,829,055 2039-03-29
Schering Corporation A Subsidiary Of Merck & Co., Inc. PEGINTRON/ REBETOL COMBO PACK peginterferon alfa-2b and ribavirin 125196 June 13, 2008 4,829,055 2039-03-29
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.